BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank50
3Y CAGR-67.5%
5Y CAGR-29.1%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-67.5%/yr
Annual compound
5Y CAGR
-29.1%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 10.17% |
| 2024 | 160.65% |
| 2023 | 15.41% |
| 2022 | 295.50% |
| 2021 | -89.55% |
| 2020 | 56.76% |
| 2019 | 18.67% |
| 2018 | -740.30% |
| 2017 | 98.17% |
| 2016 | -625.76% |